Free Access
Med Sci (Paris)
Volume 21, Number 2, Février 2005
Page(s) 187 - 189
Section M/S revues
Published online 15 February 2005
  1. Brun-Buisson C. Les DSMB. 1. Quel rôle, quelles responsabilités ? Med Sci (Paris) 2005; 1 : 78–82 [Google Scholar]
  2. Lemaire F, Brun-Buisson C. Are institutional review boards effective in safeguarding patients in intensive care units ? Curr Opin Anaesthesiol 2000; 13 : 195–201. [Google Scholar]
  3. Freeman BD, Danner RL, Banks SM, Natanson C. Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med 2001; 164 : 190–2. [Google Scholar]
  4. Wolkenstein P, Latarjet J, Roujeau JC, et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 1998; 352 : 1586–9. [Google Scholar]
  5. Naveau S, Chollet-Martin S, Dharancy S, et al. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004; 39 : 1390–7. [Google Scholar]
  6. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341 : 785–92. [Google Scholar]
  7. Bakker J, Grover R, McLuckie A, et al. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis : results of a randomized, double-blind, placebo-controlled multicenter study (study n° 144-002). Crit Care Med 2004; 32 : 1–12. [Google Scholar]
  8. Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88 : effect on survival in patients with septic shock. Crit Care Med 2004; 32 : 21–30. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.